Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Ying Wang, Dr.
CONTACT
Lead
Institute of Hematology & Blood Diseases Hospital, China
This is a single-center, one-arm, open-label study aiming to evaluate the safety and efficacy of CD19 UCAR-T Cellsin subjects with autoimmune diseases. The study process is divided into five periods, including screening, lymphodepletion, treatment, DLT observation and follow-up.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted